The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program

NCT07255131 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2026-01-27

No results posted yet for this study

Summary

An online group cognitive behavioral psychotherapeutic program will be offered to patients with cystic fibrosis and to caregivers by the Hellenic Cystic Fibrosis Association. These 2 above therapy groups will be compared with control groups in a randomized controlled trial

Conditions

  • Depression - Major Depressive Disorder
  • Anxiety Chronic
  • Anxiety
  • Functional Outcome
  • Recovery
  • Obsessive Compulsive Disorders
  • Assertiveness

Interventions

BEHAVIORAL

Group A An online group cognitive behavioral psychotherapy in 13 sessions via Zoom

An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy Group A, to patients with cystic fibrosis

BEHAVIORAL

Group B An online group supportive psychotherapy in 13 sessions via Zoom

An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control group Group B, to patients with cystic fibrosis

BEHAVIORAL

Group C An online group cognitive behavioral psychotherapy in 13 sessions via Zoom

An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy group C, to caregivers of patients with cystic fibrosis

BEHAVIORAL

Group D An online group supportive psychotherapy in 13 sessions via Zoom

An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control Group D, to caregivers of patients with cystic fibrosis

Sponsors & Collaborators

  • Rakitzi, Stavroula

    lead OTHER

Principal Investigators

  • Dr. Stavroula Rakitzi · Private Practice

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-26
Primary Completion
2028-12-20
Completion
2028-12-20

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07255131 on ClinicalTrials.gov